PineBridge Investments, L.P. - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
PineBridge Investments, L.P. ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$608,000
-33.9%
9,837
-35.8%
0.01%
-40.0%
Q3 2019$920,000
-22.3%
15,312
+9.1%
0.02%
-21.1%
Q2 2019$1,184,000
+216.6%
14,035
+258.0%
0.02%
+137.5%
Q1 2019$374,000
+37.0%
3,920
+1.7%
0.01%
+33.3%
Q4 2018$273,000
-6.8%
3,853
+12.3%
0.01%0.0%
Q3 2018$293,000
+2.1%
3,430
+38.5%
0.01%
-14.3%
Q2 2018$287,000
+23.7%
2,476
-13.8%
0.01%
+40.0%
Q1 2018$232,000
+182.9%
2,873
+62.1%
0.01%
+150.0%
Q3 2017$82,000
+24.2%
1,772
-3.2%
0.00%0.0%
Q2 2017$66,000
-90.9%
1,830
-92.3%
0.00%
-89.5%
Q1 2017$729,000
+37.3%
23,685
+49.3%
0.02%
+18.8%
Q4 2016$531,000
+1029.8%
15,860
+797.6%
0.02%
+700.0%
Q3 2016$47,000
+38.2%
1,767
+14.7%
0.00%0.0%
Q2 2016$34,000
-24.4%
1,5400.0%0.00%0.0%
Q1 2016$45,000
-22.4%
1,540
-12.4%
0.00%0.0%
Q4 2015$58,000
+7.4%
1,758
+18.5%
0.00%0.0%
Q3 2015$54,0001,4830.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,599,109$63,277,0008.68%
SENZAR ASSET MANAGEMENT, LLC 566,903$22,432,0006.58%
Sarissa Capital Management LP 105,000$4,155,0001.60%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 136,637$5,407,0001.41%
RA Capital Management 250,000$9,893,0001.17%
BENNETT LAWRENCE MANAGEMENT L L C/NY 110,515$4,373,0000.99%
Ghost Tree Capital, LLC 35,000$1,385,0000.75%
WALL STREET ASSOCIATES 159,100$6,296,0000.65%
BAILARD, INC. 91,500$3,621,0000.56%
EAM Investors, LLC 62,768$2,484,0000.50%
View complete list of ENANTA PHARMACEUTICALS INC shareholders